- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Allos Therapeutics, Inc. (ALTH)
by latest | most commented
-
FDA Calendar Updates: King Pharma, Pain Therapeutics
-
FDA Calendar: 18 Hot Summer Trades
-
Wednesday's Options Recap
-
Tuesday Options Update: GLD, LEA, ALTH, MS, FXI, XHB, EEM, BNI
-
FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
-
FDA, Clinical Trial Updates: MAP Pharma, Cytokinetics, Hemispherx Post Big Gains
-
Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
-
Where the Big Money Is Betting Big
-
Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test
-
Allos Therapeutics: Smallcap Biotech with FDA Catalyst
-
FDA, Clinical Trial Calendar Updates: Thoratec, Allos Therapeutics
-
FDA and Clinical Trial Updates: Dyax Secures Narrow Approval for Kalbitor
-
20 'Bathwater Babies' and 3 'Dogs with Fleas' for the Week
-
'When There's Blood in the Streets', Buy Biotech Stocks
-
Allos Therapeutics Looks Promising Ahead of Crucial 6 Months
-
Memorial Weekend Pharma Financing
-
Cancer Stocks: The Bleeding Slows